大行評級|高盛:維持友邦目標價98港元 續列確信買入名單內
高盛發表報吿指出,友邦20億美元額外股票回購計劃,令2024財年總回報率達8%,與擁有成熟股東回報政策的歐洲壽險公司相當。根據友邦新資本管理政策,該行預計公司在2025/26財年可維持進行20億美元的股票回購,並有自由盈餘淨額之75%分配,令總回報率保持在6.5%至7%,相比目前股息率約3%,有潛力更大程度透過債務融資進行更多回購。在基本情況下,即友邦2025/26財年進行20億美元額外回購,該行估計公司在2024至2026財年的經營溢利增長10%。該行對其目標價維持98港元,風險回報仍然吸引,續列確信買入名單內,重申對其“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.